Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects

Clinical trial NCT03802786 · COMPLETED

Trial details

NCT number: NCT03802786
Sponsor: Poxel SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2018-11-06
Primary completion: 2019-07-03
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.